A PHASE 1 STUDY TO EVALUATE THE BIOEQUIVALENCE OF ORAL TABLET AND ORALLY DISSOLVING TABLET FORMULATIONS OF RIMEGEPANT, A SMALL MOLECULE CGRP RECEPTOR ANTAGONIST
R. Croop,A. Ivans,D. Stock,J. Hould,B. A. Morris,J. Stringfellow,C. M. Jensen,J. -A. Moulin,R. Larouche,M. Tanguay,V. Coric,R. B. Lipton
